BIOMAT Database Logo BIOMAT Database Logo

Basic derivatives of 5-benzoyl-10,11-dihydro-5H-dibenz[b,f]azepine. 1983

P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
[New derivatives of 10,11-dihydro-5H-dibenz[b,f]azepine with antiarrhythmic action].
December 1985, Die Pharmazie,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
July 1999, Journal of medicinal chemistry,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
[The preparation of 5-methyl-10,11-dihydro-5H-dibenz(b,f)-azepine-10-carboxylic acid. 1. Iminobenzyl derivatives].
June 1978, Die Pharmazie,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.
March 2012, MedChemComm,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
Synthesis, anticonvulsant properties and pharmacokinetic profile of novel 10,11-dihydro-10-oxo-5H-dibenz/b,f/azepine-5-carboxamide derivatives.
March 2001, European journal of medicinal chemistry,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
Metabolism of 10,11-dihydro-10-hydroxyimino-5H-dibenz/b, f/azepine-5-carboxamide, a potent anti-epileptic drug.
February 2002, Xenobiotica; the fate of foreign compounds in biological systems,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
10,11-Dihydro-10,11-dihydroxy-5H-dibenz(b,f)azepine-5-carboxamide, a metabolite of carbamazepine isolated from human and rat urine.
June 1973, Journal of medicinal chemistry,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices.
April 2002, Pharmacology & toxicology,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
[Antiarrhythmic effectiveness of 3-carbalkoxyamino-5-(omega-aminoacyl)-10,11-dihydro-5H-dibenz-[b,f]- azepines].
December 1985, Die Pharmazie,
P Valenti, and A Poli, and P Montanari, and G Fabbri, and P Giusti, and M Carrara, and S Zampiron, and L Cima
[Synthesis of 3-carbethoxyamino-5-dimethylamino-[1-14C]-acetyl- 10,11-dihydro-5h-dibenz[b,f]azepine hydrochloride (Bonnecor, AWD 19-166, GS 015)].
December 1985, Die Pharmazie,
Copied contents to your clipboard!